SH-SY5Y neuroblastoma cells were cultured in DMEM/F12 medium (GIBCO/Life Technologies) supplemented with 10% FBS and 1% penicillin-streptomycin (Sigma-Aldrich). For assays of gene expression and ATP production, cells were plated at 200,000 cells/well in 12-well plates. For assays of cell viability, cells were plated at 15,000 cells/well in 96 well plates. Three days after plating, cells were washed with phosphate-buffered saline (PBS) and switched to serum-free DMEM/F12 medium containing 1% N-2 growth supplement (GIBCO/Life Technologies) plus STX (100 nM). The following day, the cells were treated with 50 µM Aβ25–35 (American Peptide Company), a fragment that has been shown to recapitulate the toxic effects of full-length Aβin vitro [42, 43]. Aβ25–35 solutions were incubated at 37° C for 72 hr, prior to addition to the cell cultures. All endpoints were assessed after 48 hr of treatment.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.